Biotechnology Startups in New York

Episteme Prognostics, Inc. is a pioneering precision medicine company dedicated to revolutionizing pancreatic cancer diagnosis and treatment. By focusing on the development of groundbreaking diagnostic tests, the company aims to enhance therapeutic decisions, ultimately improving patient outcomes. Their innovative technology leverages epigenetic biomarkers to provide critical insights into treatment responses for patients diagnosed with this challenging disease.

Founded 2021

Iantrek, Inc. is a pioneering medical technology company dedicated to enhancing glaucoma treatment through innovative solutions tailored for micro-interventional glaucoma surgery (MIGS). With a focus on addressing the pressing global challenge of glaucoma, a leading cause of irreversible blindness affecting over 75 million people worldwide, Iantrek is committed to improving patient outcomes and surgical precision in eye care.

Medicovestor is an early-stage biopharmaceutical company founded in 2023, focused on developing next-generation antibody-drug conjugate (ADC) platforms. The company aims to create precision medicines for solid tumors like pancreatic and ovarian cancer by overcoming the limitations of existing ADCs, particularly in tumors with low antigen expression.

Myrtelle Inc. is a clinical-stage gene therapy company carrying the mission of developing innovative treatments for neurodegenerative diseases that primarily affect myelin and white matter in the brain. With a particular focus on Canavan disease, the company addresses critical gaps in treatment options for rare genetic disorders of the central nervous system, aiming to improve patient outcomes significantly.

Founded 2021